Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Clinical trial NCT00003148 · COMPLETED
Trial details
- NCT number
- NCT00003148
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-10-01
- Primary completion
- 2001-04-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.